Levetiracetam micro-granules - Desitin
Latest Information Update: 26 Nov 2015
At a glance
- Originator Desitin Pharmaceuticals GmbH
- Developer Advicenne; Desitin Pharmaceuticals GmbH
- Class Acetamides; Antidementias; Antiepileptic drugs; Neuroprotectants; Pyrrolidinones; Small molecules
- Mechanism of Action SV2A protein modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Marketed Myoclonic epilepsies; Partial epilepsies; Tonic-clonic epilepsy
Most Recent Events
- 15 Mar 2016 Biomarkers information updated